BTLA antibody (C-Term)
Quick Overview for BTLA antibody (C-Term) (ABIN6257947)
Target
See all BTLA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- BTLA Antibody detects endogenous levels of total BTLA.
-
Predicted Reactivity
- Bovine,Horse,Sheep,Dog,Chicken
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogen
- A synthesized peptide derived from human BTLA, corresponding to a region within C-terminal amino acids.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB 1:500-1:1000, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C. Stable for 12 months from date of receipt.
-
Expiry Date
- 12 months
-
-
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Alternative Name
- BTLA
-
Background
-
Description: Lymphocyte inhibitory receptor which inhibits lymphocytes during immune response.
Gene: BTLA
-
Molecular Weight
- 33 kDa
-
Gene ID
- 151888
-
UniProt
- Q7Z6A9
-
Pathways
- Cancer Immune Checkpoints
Target
-